Cargando…

Correction to: Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631820/ https://www.ncbi.nlm.nih.gov/pubmed/37758208 http://dx.doi.org/10.1093/jac/dkad305

Ejemplares similares

Effect of dapagliflozin on COVID-19 infection and risk of hospitalization
por: Salgado-Barreira, Angel, et al.
Publicado: (2023)

Correction to: Dapagliflozin: A Review in Type 1 Diabetes
por: Paik, Julia, et al.
Publicado: (2019)

Correction to: Dapagliflozin: A Review in Type 2 Diabetes
por: Dhillon, Sohita
Publicado: (2019)

Correction: Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
por: Chang, Yoon-Kyung, et al.
Publicado: (2016)

Correction to: Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
Publicado: (2022)

Correction: Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
por: Yang, Xudong, et al.
Publicado: (2023)

Correction to: Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus
por: Shibata, Ryo, et al.
Publicado: (2022)

Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
por: Chouchana, Laurent, et al.
Publicado: (2021)

Correction: The value of the wireless stethoscope in patients with COVID-19 infection in a makeshift hospital
por: Zhuge, Ying, et al.
Publicado: (2023)

Correction to: Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection
por: Muhammad, Rizwan, et al.
Publicado: (2022)

Correction to: Asthma in patients admitted to emergency department for COVID‑19: prevalence and risk of hospitalization
por: Gabrielli, Maurizio, et al.
Publicado: (2023)

Correction: COVID-19 and transportation of India: influence on infection risk and greenhouse gas emissions
por: Soni, Arti Roshan, et al.
Publicado: (2022)

Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
por: Bailey, Clifford J, et al.
Publicado: (2013)

Correction: Predictors of pulmonary embolism in hospitalized patients with COVID-19
por: Bahk, Jeeyune, et al.
Publicado: (2023)

Correction: Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
por: Schlicht, Kristina, et al.
Publicado: (2021)

Dapagliflozin in patients with COVID-19: truth or dare
por: Rossello, Xavier, et al.
Publicado: (2021)

Dapagliflozin in patients with COVID-19: mind the kidneys
por: Reis, Thiago, et al.
Publicado: (2022)

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
por: Prabhakaran, Dorairaj, et al.
Publicado: (2022)

Correction to: Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a etrospective cohort study
por: van Halem, Karlijn, et al.
Publicado: (2020)

Correction: Predicting the number of COVID-19 infections and deaths in USA
por: Ebubeogu, Amarachukwu Felix, et al.
Publicado: (2022)

Correction to: COVID‑19 infection in pediatric patients treated for cancer
por: Oz-Alcalay, Lital, et al.
Publicado: (2021)

Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis
por: Cure, Erkan, et al.
Publicado: (2020)

Correction to: Do the benefits of exercise in indoor and outdoor environments during the COVID‑19 pandemic outweigh the risks of infection?
por: Dominski, Fábio Hech, et al.
Publicado: (2020)

Correction: The effect of risk framing on support for restrictive government policy regarding the COVID-19 outbreak
por: Chmel, Kirill, et al.
Publicado: (2022)

Correction to: Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2021)

Correction to: Fear of COVID-19 Scale for Hospital Staff in Regional Hospitals in Mexico: a Brief Report
por: García-Reyna, Benjamín, et al.
Publicado: (2021)

Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
por: Zekry, Rania, et al.
Publicado: (2023)

Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation
por: Olivas-Martínez, Antonio, et al.
Publicado: (2022)

Correction to: Reflections on designing population surveys for COVID-19 infection and prevalence
por: Swaminathan, Akshay, et al.
Publicado: (2020)

Correction to: First COVID-19 infections in the Philippines: a case report
por: Edrada, Edna M., et al.
Publicado: (2020)

Author Correction: Digit ratios and their asymmetries as risk factors of developmental instability and hospitalization for COVID-19
por: Kasielska-Trojan, A., et al.
Publicado: (2022)

Correction to: Probabilities of ICU admission and hospital discharge according to patient characteristics in the designated COVID-19 hospital of Kuwait
por: Kipourou, Dimitra-Kleio, et al.
Publicado: (2021)

Correction: The impact of COVID-19 pandemic on key performance indicators in three Saudi hospitals
por: Alharbi, Abeer, et al.
Publicado: (2023)

Correction to: Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2020)

Correction to: Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results
por: Marchese, Maria Rafaella, et al.
Publicado: (2021)

Correction: A mathematical model of COVID-19 transmission in a tertiary hospital and assessment of the effects of different intervention strategies
por: Baek, Yae Jee, et al.
Publicado: (2021)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy
por: Ghio, Stefano, et al.
Publicado: (2021)

Correction to: Risk factors associated with intensive care unit (ICU) admission and in-hospital death among adults hospitalized with COVID-19: a two-center retrospective observational study in tertiary care hospitals
por: Shayganfar, Azin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_00m49mskge1sgle63fn4ivc2k0